Truxima Patient assistance program
Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Truxima medication with our help.Get Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are qualified. The pharmaceutical company provides your medication for free and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address.
Your monthly Truxima cost savings if eligible
If you are eligible to receive your Truxima prescription through the patient assistance program, your medication will be free. We charge a flat monthly service fee of $49 per medication to cover the cost of our services.
Am I eligible for Truxima patient assistance?
To be eligible for the Truxima patient assistance program, you will need to meet specific eligibility criteria set by the pharmaceutical company. At NiceRx, we review each Truxima enrollment application individually. The main factors considered are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Truxima patient assistance program?
Applying for the Truxima patient assistance program through NiceRx is simple. Begin by completing the enrollment application on our website. We will ask for details about your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers that supply your medication. We may be able to help you access patient assistance for other medications as well as Truxima, so please tell us about any medications that you have been prescribed.
If we determine that you may be eligible for Truxima assistance, we will handle the full enrollment process on your behalf. We will work with your healthcare provider to prepare and submit all the documents required for you to enroll. If you are successfully enrolled in the Truxima patient assistance program, we will also request your Truxima medication refills on your behalf for up to 1 year. At the end of your enrollment period, we will contact you for updated details and seek to re-enroll you in the program.
Is NiceRx a Truxima coupons provider?
NiceRx does not provide Truxima coupons, discount cards, or copay cards. We do not offer printable Truxima manufacturer coupons, Truxima discounts, rebates, Truxima savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Truxima medication with NiceRx.
Can NiceRx help me get Truxima if I have insurance?
NiceRx may be able to help you access Truxima patient assistance if:
- You have a high copay or coinsurance responsibility for Truxima
- Your insurance company will not pay for your Truxima prescription
- You do not have insurance
Complete your enrollment application online to find out more.
How much does Truxima cost without insurance?
Truxima prices without insurance will vary by retailer. As a guide, Truxima intravenous solution (abbs 10 mg/mL) will typically cost around $890 for 10 milliliters.
How much does Truxima cost with insurance?
Your individual healthcare plan will determine the copay of Truxima with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.
What is Truxima?
Truxima is an FDA-approved (U.S. Food and Drug Administration) biosimilar medication manufactured by Teva Pharmaceuticals USA Inc. Truxima is highly similar in structure and function to Rituxan.
Truxima is indicated for the treatment of adult patients with:
- Non-Hodgkin’s Lymphoma (NHL) – Relapsed or refractory, low grade or follicular, CD20-positive B-cell NHL as a single agent, Previously untreated follicular, CD20-positive, B-cell NHL in combination with first-line chemotherapy, and in patients achieving a complete or partial response to a rituximab product in combination with chemotherapy, as single-agent maintenance therapy, Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL as a single agent after first-line cyclophosphamide, vincristine, and prednisone (CVP) chemotherapy
- Chronic lymphocytic leukemia (CLL)
- Adults with rheumatoid arthritis
- Adults with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)
Truxima is not to be used in the treatment of children.
What doses of Truxima are available?
Truxima is available in injection form, in the following doses: 100 mg/10 mL (10 mg/mL) and 500 mg/50 mL (10 mg/mL) solution in single-dose vials.
Truxima should only be administered by a healthcare professional as an intravenous infusion with medical support to manage severe infusion reactions that can be fatal if they occur. The dose for NHL is 375 mg/m2.
See full prescribing information for a complete boxed warning. Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Truxima active ingredients
Rituximab-abbs is a monoclonal antibody. Rituximab products target the CD20 antigen expressed on the surface of pre-B and mature B-lymphocytes. Once bound to CD20, rituximab products mediate B-cell lysis. The possible mechanism of action of cell lysis includes complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC). B cells are thought to play a role in the pathogenesis of rheumatoid arthritis (RA) and associated chronic synovitis.
Truxima side effects
The most common side effects of Truxima in clinical trials include:
- Infusion reactions
- Nausea, diarrhea
- Low white and red blood cells – chills, fever, aches, fatigue
- Swelling in your hands or feet
- Headache, weakness
- Painful urination
In rare instances, Truxima can cause more serious side effects. These can include:
- Tumor lysis syndrome (TLS)
- Serious infections
- Cardiac adverse reactions
- Bowel obstruction and perforation – evaluate for abdominal pain, vomiting, or related symptoms
- Fatal infusion reactions within 24 hours of rituximab infusion – approximately 80% of fatal reactions occurred with the first infusion. Monitor patients and discontinue Truxima infusion for severe reactions
- Severe mucocutaneous reactions – some with fatal outcomes
- Hepatitis B virus (HBV) reactivation – in some cases resulting in fulminant hepatitis, hepatic failure, and death
- Progressive multifocal leukoencephalopathy (PML) resulting in death
Your doctor will assess the benefits of using Truxima against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Truxima to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Truxima drug interactions
Truxima can interact with other medications. These include:
- Renal toxicity when used in combination with cisplatin
- DMARDs – observe for signs of infection when given treatment
- Live virus vaccinations before or during treatment are not recommended. Administration of non-live vaccines should occur at least 4 weeks prior to a course
- Serious brain infection can lead to disability or death. This may be more likely if you have used an immunosuppressant in the past, or if you have received this medicine with a stem cell transplant
This list is not exhaustive and other drugs may interact with Truxima.
You should not use Truxima if you:
- Are allergic to the active ingredient rituximab
- Are allergic to any of the other ingredients in Truxima
- Are pregnant or are planning to become pregnant – Embryo-Fetal toxicity can occur. Use effective birth control (contraception) to prevent pregnancy while you are using Truxima and for at least 12 months after your last dose
Talk to your doctor before using Truxima if you:
- Are taking any of the medications that could interact with Truxima
- Are breastfeeding or are planning to breastfeed – do not breastfeed while using this medicine, and for at least 6 months after your last dose
- Have liver disease or hepatitis
- Have an infection such as herpes, shingles, cytomegalovirus, chickenpox, parvovirus, West Nile virus, or hepatitis B or C
- Have kidney disease
- Have lung disease or a breathing problem
- Have a weak immune system
- Have heart problems, angina (chest pain), or heart rhythm disorder
Truxima is the trademark brand name for rituximab manufactured by Teva Pharmaceuticals USA, Inc. A generic version of rituximab is available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Truxima savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.